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ABSTRACT. Structure and microarchitecture are
determinant aspects of bone strength and essen-
tial elements for the assessment of bone me-
chanical properties. The main structural determi-
nants of bone mechanical strength include width
and porosity in the cortical bone; shape, width,
connectivity, and anisotropy in the trabecular
bone. There are several methods to assess bone
architecture, particularly at the trabecular level.
Two different approaches can be identified. The
first is based on the use of optical microscopy and
on the principles of quantitative histology, which
evaluate microarchitecture two-dimensionally. The
second applies the most modern diagnostic tech-
niques, employing computed tomography and
magnetic resonance to obtain and analyze three-
dimensional images. From a clinical point of
view, microarchitecture is an interesting aspect
to study and define specific patterns, such as
glucocorticoid-induced osteoporosis, or to eval-
uate bone alterations in transplanted patients.
Microarchitecture seems to be a determinant of
bone fragility independent of bone density.
Moreover, bone microarchitecture seems to be
important to understand the mechanisms of bone
fragility as well as the action of the drugs used to
prevent osteoporotic fractures. Several in vivo
studies (on animals and humans) showed impor-
tant findings on the effects of different treat-
ments on microarchitecture. Bisphosphonates and
parathyroid hormone seemed to preserve or even
improve microarchitecture. These observations
can provide an additional interpretation for the
anti-fracture effect of drugs from a structural view-
point. The challenge for the future will be to eval-
uate bone quality in vivo with the same or better
resolution and accuracy than the invasive meth-
ods in use today. 
(J. Endocrinol. Invest. 27: 99-105, 2004)
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INTRODUCTION
The increasing use of densitometric devices for as-
sessing bone fragility has progressively strength-
ened the assumption that mass is by large the most
important property determining bone mechanical
competence. However, numerous observations in-
dicate that bone strength is only partially explained
by bone density. Bone shape and internal structure,
which are influenced by load and different stimuli
and stresses, are crucial elements that contribute
to the definition of bone distinctive characteristics.
The interaction between the genetic species-spe-
cific elements and the environmental individual-
specific stimuli occurs through a structure that can
provide the best resistance to load, stress or com-
pression, on account of the spatial orientation of
the trabecular network as well. 
The main structural determinants of bone mechani-
cal strength include width and porosity in the corti-
cal bone; shape, width, connectivity, and anisotropy
in the trabecular bone. Structure and microarchitec-
ture are therefore determinant aspects of bone
strength and essential elements for the assessment
of bone mechanical properties and changes. For in-
stance, it has been observed that during age-related
bone involution the loss of entire trabeculae would
result in higher loads and consequently in the thick-
ening of the remaining elements. In particular, the
number of horizontal trabeculae decreases through-
out life, whereas vertical trabeculae are resorbed
more slowly and tend to increase in width with age
Key-words: Bone density, bone strength, fractures, histomorphometry,
microarchitecture, μCT.
Correspondence: Luca Dalle Carbonare, MD, Dipartimento di Scienze
Mediche e Chirurgiche, Clinica Medica I, Università di Padova, Via
Giustiniani 2, 35128 Padova, Italy.
E-mail: luca.dallecarbonare@unipd.it
Accepted July 18, 2003.
REVIEW ARTICLE
Bone microarchitecture as an important determinant 
of bone strength
L. Dalle Carbonare, and S. Giannini
Department of Medical and Surgical Sciences, Medical Clinic I, University of Padova, Padova, Italy
Bone microarchitecture and bone strength
100
(1). This is probably due to the fact that the load in
vertebral cancellous bone is mainly placed on the
vertical elements, thus the compensatory hypertro-
phy or thickening effect is only to be expected in the
vertical trabeculae.
From another point of view, it has also been ob-
served (2) that the increases in bone mass record-
ed after drug therapies for osteoporosis can just
partly explain the decrease in fracture incidence af-
ter these treatments. Therefore, other aspects, such
as microarchitecture, may contribute to the deter-
mination of bone mechanical competence. In ad-
dition, the effect of some of these therapies on mi-
croarchitecture contributes to explaining their ef-
ficacy and rapidity of action. 
Consequently, there is growing interest in the quan-
titative assessment of this particular morphological
aspect of the bone. 
METHODS TO ASSESS MICROARCHITECTURE
There are several methods to assess bone archi-
tecture, particularly at the trabecular level, that is,
to detect the organization of bone in space and to
measure the complexity of its structure quantita-
tively. Two different approaches can be basically
identified. The first makes use of optical mi-
croscopy and is based on the principles of histo-
morphometry (that is, quantitative histology in-
spired to stereology), which evaluates microarchi-
tecture on two-dimensional (2-D) bone sections.
The second applies the most modern diagnostic
techniques, employing computed tomography (CT)
and magnetic resonance (MR) to obtain three-di-
mensional (3-D) images on which bone microar-
chitectural organization can be assessed. Various
techniques have been used to create 3-D imaging
of bone. The most significant among them are
based on the rebuilding of 3-D size from 2-D seri-
al sections of bone biopsies, using stereo- and
scanning microscopy, volumetric and micro-CT,
and micro-MR (3, 4). High-resolution tomography
and MR are interesting new approaches employed
in vivo, which can evaluate microarchitecture, but
at present with lower spatial resolution.
The study of microarchitecture is based on the
measure of width, number, and separation of tra-
beculae as well as on their spatial organization. The
latter, defined as connectivity, is a 3-D property
that describes the typology of the various connec-
tions between the so-called nodes (the structural
units that represent the confluence of two or more
trabeculae) and the connecting segments (struts
and termini). From a quantitative standpoint, con-
nectivity is an index of the variety of links among
the trabeculae and can be defined as the major
number of connections that can be broken before
structure integrity is completely lost (5).
2-D METHODS
The first approaches to quantitative evaluation of
trabecular bone structure were based on the direct
and indirect measure of trabecular width, separa-
tion, and number (6-8). The direct measurement of
trabecular width was initially obtained by using a
microscope with an ocular equipped with a special
grid. The trabecular number and separation de-
scribe the basic relationship between space and
trabecular network. The trabecular number is de-
fined as (BV/TV)/Tb.Th, where BV is Bone Volume,
TV is the volume of the examined tissue, and Tb.Th
is the thickness of the trabeculae. Conventionally,
all these parameters are expressed as volume in-
stead of area, even if they are evaluated in 2-D sec-
tions, because they offer an inferred estimation of
the spatial organization of the trabecular network.
Similarly, the trabecular separation, defined as the
distance between the edges of the trabeculae, is
expressed in 3-D units (9).
More recently, new computerized methods that al-
low the acquisition of more sophisticated mea-
surements by means of a digitizer have been in-
troduced to integrate the use of the microscope
(10, 11). These methods supply information on tra-
becular width as well as on its distribution and on
the organization of the different trabeculae in a
bone section. For instance, through the process of
“skeletonization” of the trabecular bone on 2-D
sections by a computed analysis, it is possible to
obtain a network of 2-D components, called struts,
which reproduces the trabecular distribution in
space (12, Fig. 1). The link between two or more
struts constitutes a node. When one side of a strut
is not joined to a node it is referred to as “free
end” or “termini”, which represents an interrup-
tion in the trabecular network (13). The ratio be-
tween nodes and termini in a section is an index
of spatial connectivity.
Other parameters that allow an indirect evaluation
of the trabecular connectivity, through the assess-
ment of the marrow connectivity, are:
- The marrow star volume (MaSV), i.e. the mean
volume of all the parts of an object that can be
unobscured in all the directions from a point in-
side the object (14, Fig. 2); 
- The trabecular bone pattern factor (TBPf), i.e. the
relation between convex and concave elements,
considering a concave element as the expression
of a well connected structure (15); 
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- The index of interconnectivity (ICI), after ske-
letonization of the bone marrow, defined as
(NxNN)/[Tx(NF+1)], where N is the number of
nodes, NN is the number of node-to-node branch-
es, NF is the number of node-to-terminus branch-
es, and T is the number of “trees”, a tree being
an independent portion of the medullary space
totally enclosed by a trabecular structure (16);
- The Euler number, expressed per tissue volume
(E/TV), i.e. the number of holes minus the number
of connected components, which can be interpret-
ed as the maximum number of branches that could
be removed without breaking the network into dif-
ferent parts (17);
- The “fractal” analysis, which describes how an ob-
ject fills space with relation to its structure (18). This
parameter allows an evaluation of bone structural
anisotropy, too.
Each of these parameters gives a distinctive analysis
of the trabecular bone architecture. All the above-
mentioned 2-D approaches are limited by the ne-
cessity to infer 3-D information from a 2-D evalua-
tion. Nevertheless, there are several pieces of evi-
dence confirming that measurements on 2-D sec-
tions are well correlated to the 3-D structure and
properties of bone (17).
3-D METHODS
Since the structural determinants of trabecular bone
strength are 3-D features, their evaluation on con-
ventional histological sections offers only indirect in-
formation on these properties. 3-D images are there-
fore necessary to obtain the direct measurement of
trabecular connectivity, anisotropy, and shape. These
approaches enable the measurement of the struc-
tural indices corresponding to width, number, and
“apparent” trabecular separation, which are param-
eters that define microarchitecture at a 3-D level.
They also make it possible to confirm the anisotrop-
ic structure of the trabecular bone, allowing the 3-D
analysis of connectivity.
Quantitative CT (QCT) and, in particular, volumetric
QCT (vQCT) are 3-D methods used to assess the
macrostructure of bone quantitatively. With regard
to trabecular bone microarchitecture, noninvasive
and/or nondestructive 3-D methods include high-
resolution CT (hrCT), micro-CT (μCT), high-resolution
MR (hrMR), and micro-MR (μMR) vQCT, hrCT, and
hrMR are generally applicable in vivo, whereas μCT
and μMR are principally applicable in vitro. The po-
tential ability of MR and CT to provide information
on in vivo bone structure is an important and active
research area, even if at present some applications
are limited by the still reduced spatial resolution of
methods and signal-to-noise ratio as well as by the
complexity and cost of equipment. 
In vivo, the use of standard QCT in the volumetric
assessment (vQCT) can determine the bone mineral
content or the bone mineral density (BMD) of the en-
tire bone or subregion (vertebral body or femoral
neck), as well as provide a separate analysis of the
trabecular or cortical components. This method sup-
plies a 3-D pool of densitometric measurements,
each corresponding to one small volume. As the 3-
D parameters of each volume are preserved, all the
single units can be examined in every direction. In
addition, using the accurate volumetric rendering al-
Strut analysis
Fig. 1 - Strut analysis. Black squares represent the nodes, that
is, the connection between three or more struts (segments rep-
resenting a trabecula, white points). Grey rhombi represent the
free-ends or termini, which are ends of trabeculae or broken,
interupted elements of the trabecular network.
Marrow star volume
Fig. 2 - Representation of marrow star volume. This parameter rep-
resents the mean volume of all the parts of an object that can be
unobscured in all the directions from a point inside the object. By
the analysis of marrow space distribution, we obtain an indirect
evaluation of the trabecular network organization. The higher the
mean of the segments, the lower the trabecular connectivity.
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lowed by this technique, important geometrical and
biomechanical information can be obtained. For in-
stance, in a study using this approach a good corre-
lation between resistance to compression and ap-
parent density was recorded (19). 
Another method employing 3-D images in vivo is
based on the use of hrMR, applied for instance to
distal radius. It has recently been observed that
this technique makes it possible to detect sub-
jects with fractures on the basis of differences in
microarchitecture parameters in a population of
postmenopausal osteoporotic women (20). 
3-D technology in vivo using high-spatial-resolution
MR imaging (MRI) and multisection CT can also be
applied to depict regional structural variations of tra-
becular bone in specific subregions of skeletal sites.
This interesting approach seems to allow the evalu-
ation of focal microarchitectural alterations (21).
As regards 3-D methods in vitro, μCT is based on
the acquisition of 2-D serial images, which are
then integrated by the computer to rebuild a 3-D
image with resolution ranging from 10 to 70 μm.
Binary images can be produced and connectivity
and anisotropy can be assessed directly with the
Euler number or another parameter by using 3-D
reconstruction from a serial section.
This information cannot be obtained with a 2-D his-
tological approach, even if in a recent study on an
animal model evaluation of microarchitecture ob-
tained from 2-D and 3-D approaches was consistent
with glucocorticoid-induced osteopenia (22). 
CLINICAL IMPORTANCE OF
MICROARCHITECTURE
From a clinical point of view, microarchitecture is an
interesting aspect to study and define specific pat-
terns. Some years ago, Grotz observed that the eval-
uation of bone architecture, performed by hrCT,
showed differences between renal allograft recipi-
ents and patients with osteoporosis, despite similar
bone density (23). More recently, it has been ob-
served that hrMR structural measures of the calca-
neous in combination with BMD of the lumbar spine
can be used to characterize fracture incidence in kid-
ney transplanted patients (24).
Another interesting pattern for the study of microar-
chitecture is corticosteroid-induced osteoporosis,
since an important disproportion between the in-
crease in fracture rate and the decrease in bone mass
is observed. This suggests an effect of steroids on
the bone structure independent of bone density.
There is only little evidence in literature considering
microarchitecture evaluation in this particular clinical
condition. In a histomorphometric study on bone
biopsies, Chappard et al. (25) reported a structural
alteration in patients chronically treated with steroids,
which is characterized by a decrease in the trabecu-
lar network organization with impairment of connec-
tivity. When patients treated with steroids were di-
vided into two groups according to trabecular bone
volume (BV/TV>or<11%), microarchitecture param-
eters differed clearly. Trabeculae were well-connect-
ed in the group with BV/TV>11%, which also sug-
gested a possible threshold for the appearance of
structural alterations in that particular model. 
Another aspect of the importance of microarchitec-
ture assessment in understanding the pathophysiol-
ogy of the different kinds of bone fragility was
demonstrated in a study comparing corticosteroid-in-
duced osteoporosis with idiopathic osteoporosis. In
that case, it was observed that with the same bone
mass loss idiopathic osteoporosis was characterized
by an early increase in the trabecular perforations,
while corticosteroid-induced osteoporosis was asso-
ciated with progressive thinning of trabeculae with-
out early perforation (26, Fig. 3).
As regards this aspect, we observed that microar-
chitecture assessment can provide peculiar informa-
tion and that the cumulative dose of steroids plays
an essential role in microarchitectural bone alter-
ations. Patients treated with 10 g of prednisone
showed a trabecular network dramatically and irre-
versibly impaired in comparison with patients treat-
ed with lower cumulative doses (27, Fig. 4 and 5).
MICROARCHITECTURE AND FRACTURES
With regard to the relationship between microarchi-
tecture and fractures, some recent observations
seem to confirm that microstructural alterations are
important determinants of bone fragility, even inde-
pendently of bone density. In a recent study on the
evaluation of bone turnover, density, mechanical
Fig. 3 - Different pathways in idiopathic and glucocorticoid-in-
duced osteoporosis (23).
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properties, and microarchitecture using MRI in os-
teopenic patients, the correlations between the mea-
sures of bone architecture, such as “apparent tra-
becular number and separation” and different elas-
tic moduli (i.e. load and torsion), were higher than
those between elastic moduli and BMD (28). In an-
other study on orchidectomized rats, the evaluation
of microarchitectural parameters such as MaSV, frac-
tal dimension, and node count were dramatically af-
fected, thus confirming that bone loss and fragility
secondary to orchidectomy was associated with tra-
becular perforation and reduction of the complexity
of trabecular network (29). 
Finally, in another study on men affected by idio-
pathic osteoporosis, Legrand et al. (30) observed that
the differences in bone microarchitecture parame-
ters with the same mass and bone volume were the
only discriminating factor between patients with or
without vertebral fracture. 
All these observations confirm that microarchitecture
is an independent factor of bone fragility.
MICROARCHITECTURE AND TREATMENT
Bone microarchitecture seems important to under-
stand the mechanisms of bone fragility as well as the
action of the drugs used to prevent osteoporotic frac-
tures. The exact mechanism of the anti-fracture effect
of drugs inhibiting resorption, such as alendronate,
risedronate, and raloxifene has not yet been com-
pletely explained, and increases in bone mass alone
cannot account for their efficacy. Therefore, more at-
tention has been lately paid to microarchitecture eval-
uation as a peculiar feature of bone quality, which is
one of the targets of the drugs currently in use. For in-
stance, a histomorphometric study on patients un-
dergoing 3-yr therapy with alendronate showed that
bone lamellar architecture was preserved with no
qualitative alteration after treatment (31).
More recently, in a study on animals using 3-D μCT
it was observed that, compared to controls, rise-
dronate could preserve bone microarchitecture. The
maintenance of microarchitecture was associated
with better bone strength, thus confirming the close
correlation between structure and bone strength (32).
Based on the latter observations, a re-analysis of the
data related to the vertebral efficacy with risedronate
therapy - North America (VERT-NA) study on rise-
dronate treatment has been made in order to veri-
fy its possible effect on human bone structure.
Thirty-eight biopsies of the patients under investi-
gation (21 of the treated patients and 17 of the con-
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Fig. 4 - Parameters of microarchitec-
ture in patients after low glucocorticoid
cumulative dose (LGC; <10 g) vs high
dose (HGC; >10 g) and postmenopausal
osteoporosis (PMO) (24).
*: p<0.05; **: p<0.005; ***: p<0.0005.
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Fig. 5 - Different models in postmenopausal and glucocorti-
coid-induced osteoporosis, based on cumulative dose.
Bone microarchitecture and bone strength
104
trol group) were therefore re-analyzed by 3-D re-
building using μCT (33). In this case too, the analysis
showed the preservation of microarchitecture in pa-
tients treated with risedronate for 3 yr. 
Other recent studies on dogs showed that trabec-
ular microarchitecture evaluated with μCT on the
lumbar vertebral specimen was improved both af-
ter short and long-term treatment with bisphos-
phonates (34, 35).
The studies on the use of parathyroid hormone also
confirm its action on microarchitecture, which can
provide an interpretation for its anti-fracture effect
from a structural viewpoint. Analysis of cancellous
bone structure in 3-D by μCT showed maintenance
of cancellous bone volume, particularly in women.
Through this approach with μCT, it has also been ob-
served that this treatment exerts an increase in the
trabecular connectivity and induces an anabolic ef-
fect at the cortical level in the treated subjects. In
these subjects there was evidence of an anabolic ef-
fect, particularly on the endosteal surface, where an
increase in the packet wall width was observed (36).
This anabolic effect on cortical bone was consistent
with increased mechanical strength (37). In addition,
the evaluation of microarchitecture in rats treated for
a long time with PTH showed that its skeletal effects
are a complex function of dose and duration. On the
other hand, in the rat model, short-term treatment
seems to be more effective than near-life treatment,
because PTH stimulates skeletal growth throughout
life, resulting in abnormal architecture (38).
Undoubtedly, further studies will be necessary to
confirm and thoroughly investigate these acquisi-
tions. We will then be able to understand the exact
pathophysiologic mechanisms leading to bone
fragility and find new therapeutic strategies to face
the serious consequences of osteoporosis and other
metabolic bone diseases.
CONCLUSIONS
Microarchitecture is an important element of bone
quality and its integrity contributes to bone me-
chanical competence. The assessment of microar-
chitecture may be useful to evaluate the risk of frac-
ture as well as the drug mechanism of action.
In the last decade several methods, from the tra-
ditional quantitative histology improved by com-
puted analyses, to the recent applications of CT
and MR, have been devised and applied to assess
this specific bone property.
The challenge for the future will be to evaluate bone
quality in vivo with the same or better resolution and
accuracy than the invasive methods in use today. This
goal would be essential to introduce the evaluation
of such an important determinant of bone strength as
microarchitecture in the routine diagnostic approach
to skeletal diseases inducing fragility.
REFERENCES
1. Atkinson P.J. Variation in trabecular structure of vertebrae
with age. Calcif. Tissue Res. 1967, 1: 24-32
2. Chesnut III C.H., Rosen C.J. Reconsidering the effects of
antiresorptive therapies in reducing osteoporotic fracture.
J. Bone Miner. Res. 2001, 16: 2163-72
3. Majumdar S., Genant H.K. A review of the recent ad-
vances in magnetic resonance imaging in the assessment
of osteoporosis. Osteoporos. Int. 1995, 5: 79-92
4. Genant H.K., Engelke K., Fuerst T., et al. Noninvasive as-
sessment of bone mineral and structure: state of the art.
J. Bone Miner. Res. 1996, 11: 707-30
5. DeHoff R.T., Aigeltinger E.H., Craig K.R. Experimental de-
termination of the topological properties of three-dimen-
sional microstructures. J. Microsc. 1972, 95: 69
6. Wakamatsu E., Sisson H.A. The cancellous bone of the il-
iac crest. Calcif. Tissue Res. 1969, 4: 147-61
7. Whitehouse W.J. The quantitative morphology of
anisotropic trabecular bone. J. Microsc. 1974, 101: 153-68
8. Aaron J.E., Makins N.B., Sagreiya K. The microanatomy
of trabecular bone loss in normal aging men and women.
Clin. Orthop. Related Res. 1987, 215: 260-71
9. Parfitt A.M., Drezner M.K., Glorieux F.H., et al. Bone
Histomorphometry: standardization of nomenclature, sym-
bols, and units. J. Bone. Miner. Res. 1987, 2: 595-610
10. Clermonts E.C.G.M., Birkennhäger-Frenkel D.H. Software
for bone histomorphometry by means of a digitizer.
Comput. Math. Prog. Biomed. 1985, 21: 185-94
11. Garrahan N.J., Mellish R.W.E., Vedi S., Compston J.E.
Measurement of mean trabecular plate thickness by a new
computerized method. Bone 1987, 8: 227-30
12. Garrahan N.J., Mellish R.W.E., Compston J.E. A new method
for two-dimensional analysis of bone structure in human ili-
ac crest biopsies. J. Microscopy 1986, 142: 341-9
13. Parfitt A.M. Remodeling and microstructure of bone: re-
lation to prevent of age related fracture. In: Vagenakis A.,
Soucacos P., Avramides A., Segre G., Deftos L. (Eds.).
Second international conference on osteoporosis: social
and clinical aspects. Masson Italia Editori SIA, Milano,
1986, p. 197-209
14. Vesterby A., Gundersen H.J.G., Melsen F. Star volume of
marrow space and trabeculae of the first lumbar vertebra:
sampling efficiency and biological variation. Bone 1989,
10: 7-13
15. Vogel M., Hahn M., Caselitz P., Woggan J., Pompesius-
Kempa M., Delling G. Comparison of trabecular bone struc-
ture in man today and an ancient population in Western
Germany. In: Takahashi H.E. (Ed.). Bone Morphometry.
Nishimura Co., Ltd., Niigata, Japan, 1990, p. 220-3
16. Le H.M., Holmes R.E., Shors E.C., Rosenstein D.A. Com-
puterized quantitative analysis of the interconnectivity
L. Dalle Carbonare, S. Giannini
105
of porous biomaterials. Acta Stereol. 1992, 11 (Suppl 1):
267-72
17. Feldkamp L.A., Goldstein S.A., Parfitt A.M., Jesion G.,
Kleerekoper M. The direct examination of three-dimen-
sional bone architecture in vitro by computed tomogra-
phy. J. Bone Miner. Res. 1989, 4: 3-11
18. Weinstein R.S., Majumdar S. Fractal geometry and verte-
bral compression fractures. J. Bone Miner. Res. 1994, 9:
1797-802
19. McBroom R.J., Hayes W.C., Edwards W.T., Goldberg R.P.,
White A.A. III Prediction of vertebral body compressive
fracture using quantitative computed tomography. J.
Bone Joint. Surg. 1985, 67: 1206-14
20. Laib A., Newitt D.C., Lu Y., Majumdar S. New model-in-
dependent measures of trabecular bone structure applied
to in vivo high resolution MR images. Osteoporos. Int.
2002, 13: 130-6
21. Issever A.S., Vieth V., Lotter A., et al. Local differences in
the trabecular bone structure of the proximal femur de-
picted with high-spatial-resolution MR imaging and mul-
tisection CT. Acad. Radiol. 2002, 9: 1395-406
22. McLaughlin F., Mackintosh J., Hayes B.P., et al. Glucocorticoid-
induced osteopenia in the mouse as assessed by histo-
morphometry, microcomputed tomography, and bio-
chemical markers. Bone 2002, 30: 924-30
23. Grotz W.H., Mundinger F.A., Müller C.B., et al. Trabecular
bone architecture in female renal allograft recipients – as-
sessed by computed tomography. Nephrol. Dial.
Transplant. 1997, 12: 564-9
24. Link T.M., Saborowski O., Kisters K., et al. Changes in cal-
caneal trabecular bone structure assessed with high-res-
olution MR imaging in patients with kidney transplanta-
tion. Osteoporos. Int. 2002, 13: 119-29
25. Chappard D., Legrand E., Basle M.F., et al. Altered tra-
becular architecture induced by corticosteroids: a bone
histomorphometric study. J. Bone Miner. Res. 1996, 11:
676-85
26. Aaron J.E., Francis R.M., Peacock M., Makins N.B.
Contrasting microanatomy of idiopatic and corticosteroid-
induced osteoporosis. Clin. Orthop. 1989, 243: 294-305
27. Dalle Carbonare L., Arlot M.E., Chavassieux P.M., Roux
J.P., Portero N.R., Meunier P.J. Comparison of trabecular
bone microarchitecture and remodeling in glucocorticoid-
induced and post-menopausal osteoporosis J. Bone
Miner. Res. 2001, 16: 97-103
28. Newitt D.C., Majumdar S., van Rierbergen B., et al. In vivo
assessment of architecture and micro-finite element analy-
sis derived indices of mechanical properties of trabecular
bone in the radius. Osteoporos. Int. 2002, 13: 6-17
29. Audran M., Chappard D., Legrand E., Libouban H., Baslé
M.F. Bone microarchitecture and bone fragility in men:
DXA and histomorphometry in humans and in orchidec-
tomized rat model. Calcif. Tissue Int. 2001, 69: 214-7 
30. Legrand E., Chappard D., Pascaretti C., et al. Trabecular
bone microarchitecture, bone mineral density, and verte-
bral fractures in male osteoporosis. J. Bone Miner. Res.
2000, 15: 13-9
31. Chavassieux P.M., Arlot M.E., Reda C., Wei L., Yates A.J.,
Meunier P.J. Histomorphometric assessment of the long-
term effects of alendronate on bone quality and remod-
eling in patients with osteoporosis. J. Clin. Invest. 1997,
100: 1475-80
32. Borah B., Dufresne T.E., Chmielewski P.A., Gross G.J.,
Prenger M.C., Phipps R.J. Risedronate preserves trabec-
ular architecture and increases bone strength in ovariec-
tomized minipigs, as measured by 3-Dimensional micro-
computed tomography. J. Bone Miner. Res. 2002, 17:
1139-47
33. Borah B., Dufresne T., Chmielewski P., Prenger M.,
Eriksen E.F. Risedronate (Ris) preserves trabecular bone
architecture in osteoporotic postmenopausal women as
measured by 3-D micro-computed tomography: effects
of bone turnover. J. Bone Miner. Res. 2001, 16 (Suppl.
1): S218
34. Ding M., Day J.S., Burr D.B., et al. Canine cancellous bone
microarchitecture after one year of high-dose bisphos-
phonates. Calcif. Tissue Int. 2003 online publication 
35. Komatsubara S., Mori S., Mashioba T., et al. Long-term
treatment of icandronate disodium accumulates micro-
damage but improves the trabecular bone microarchitec-
ture in dog vertebra. J. Bone Miner. Res. 2003, 18: 512-20
36. Dempster D.W., Cosman F., Kurland E.S., et al. Effect
of daily treatment with parathyroid hormone on bone
microarchitecture and turnover in patients with osteo-
porosis: a paired biopsy study. J. Bone Miner. Res.
2001, 16: 1846-53
37. Zanchetta J.R., Bogado C.E., Ferretti J.L., et al. Effects of
teriparatide [recombinant human parathyroid hormone (1-
34)] on cortical bone in postmenopausal women with os-
teoporosis. J. Bone Miner. Res. 2003, 18: 539-43
38. Sato M., Vahle J., Schmidt A., et al. Abnormal bone mi-
croarchitecture and biomechanical properties with near-
lifetime treatment of rats with PTH. Endocrinology 143:
3230-42
